NCCC Meeting 6 Agenda

Time	Session
12:50–12:55 p.m.	Welcome, roll call, and review of the agenda Linda Harris, PhD Designated Federal Officer Office of Disease Prevention and Health Promotion Office of the Assistant Secretary for Health U.S. Department of Health and Human Services Clydette Powell, MD, MPH Technical Lead Office of Disease Prevention and Health Promotion Office of the Assistant Secretary for Health U.S. Department of Health and Human Services William H. Herman, MD, MPH Chair, National Clinical Care Commission
12:55–1:00 p.m.	Diabetes Prevention and Care Model Linda Harris, PhD Designated Federal Officer Office of Disease Prevention and Health Promotion Office of the Assistant Secretary for Health U.S. Department of Health and Human Services William H. Herman, MD, MPH Chair, National Clinical Care Commission
1:00–1:20 p.m.	Achieving Health Equity and Disparities in Diabetes Cara James, Director, CMS Office of Minority Health Meagan Khau, Director, Data and Policy Analytics Group
1:20–1:30 p.m.	Achieving Health Equity and Disparities in Diabetes Q&A
1:30–2:05 p.m.	Medicare Coverage, Durable Medical Equipment, & Program Integrity Beth Koller, MD, FACE, Coverage and Analysis Group Joel Kaiser, Director, Division of Durable Medical Equipment Prosthetics, Orthotics, and Supplies (DMEPOS) Policy Jill Nicolaisen, Senior Technical Advisor, Center for Program Integrity Jennifer Phillips, Center for Program Integrity
2:05–2:15 p.m.	Medicare Coverage, Durable Medical Equipment, & Program Integrity Q&A
2:15–2:45 p.m.	Diabetes Self-Management Education & Training, Virtual Care, & Other Provider Types Delivering Diabetes Care Jennifer Lloyd, PhD, MA Beth Koller, MD, FACE, Coverage and Analysis Group Marge Watchorn, Deputy Director, Division of Practitioner Services Gift Tee, Director, Division of Practitioner Services
2:45–3:00 p.m.	Diabetes Self-Management Education & Training, Virtual Care, & Other Provider Types Delivering Diabetes Care Q&A
3:00–3:15 p.m.	BREAK
3:15–3:45 p.m.	Access to Part D Drugs & Formulary Review Stephanie Hammonds, PharmD, RPh, Robert Dombrowski, Deputy Director, Division of Formulary and Benefit Operations
3:45–4:00 p.m.	Access to Part D Drugs & Formulary Review Q&A
4:00–4:20 p.m.	Section 1115 Demonstrations, Non-Emergency Medical Transportation, Medicaid Core Set Judith Cash, Director, State Demonstrations Group Alissa DeBoy, Director, Disabled and Elderly Health Programs Group Kirsten Jensen, Director, Division of Benefits & Coverage Melissa Harris, Deputy Director, Disabled and Elderly Health Programs Group Karen Matsuoka, Director, Division of Quality & Health Outcomes
4:20–4:30 p.m.	Section 1115 Demonstrations, Non-Emergency Medical Transportation, Medicaid Core Set Q&A
4:30–4:50 p.m.	Model Testing and the Medicare Diabetes Prevention Program Nina Brown-Ashford, Deputy Director, Prevention and Population Health Group Elizabeth Mathews, Director, Division of Health Care Delivery
4:50–5:00 p.m.	Model Testing and the Medicare Diabetes Prevention Program Q&A
5:00–5:15 p.m.	Oral Public Comments
5:15 p.m.	Adjournment